home-hospital Hospital-level care for acutely ill adults in the comfort of their own home.
Learn more
home-hospital
Hospital-level care for acutely ill adults in the comfort of their own home. Learn more

Press Releases

PRESS RELEASES

Biofourmis Announces National Rollout of the Biovitals® Hospital@Home™ Platform to Help Deliver Hospital-Level Care in the Home Aligned with New CMS Program

Biofourmis, a Boston-based global leader in digital therapeutics and virtual care that powers personalized predictive care, announces the national rollout of Biovitals® Hospital@HomeTM—an artificial intelligence-based, turnkey technology platform that enables hospitals and health systems to quickly deploy a “hospital at home” program.

December 3, 2020

Biofourmis’ AI-Powered Remote Monitoring Platform Deployed to Monitor COVID-19 Patients in Singapore

BOSTON and SINGAPORE, July 29, 2020 /PRNewswire/ — and July 30, 2020 – Biofourmis , a global leader in digital therapeutics that powers personalized predictive care, announced today that its Biovitals® Sentinel platform has been deployed by the Ministry of Health (MOH) in Singapore to remotely monitor COVID-19-positive patients to aid in early detection of deterioration and to enable clinicians and nurse teams to intervene early.

July 29, 2020

Digital Therapeutics Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health

Biofourmis, a global leader in digital therapeutics that powers personalized predictive care, announced today it has finalized an agreement to acquire Gaido Health from Takeda Pharmaceuticals, a strategic deal that expands Biofourmis’ portfolio in the oncology space. Gaido Health—a Los Angeles-area based digital therapeutics company focused on the oncology market—was part of Takeda Digital Ventures, Takeda’s corporate technology investment and incubation arm.

April 16, 2020

Biofourmis’ AI-Powered Remote Monitoring Platform to Provide New Insights to Fight COVID-19 in Disease Monitoring Program in Hong Kong

Biofourmis, a global leader in digital therapeutics that powers personalized predictive care, announced today that its technology is being leveraged in a remote monitoring and disease surveillance program in Hong Kong involving patients with diagnosed or suspected novel coronavirus disease (COVID-19). The program—administered by The University of Hong Kong—also includes Hong Kong-based Harmony Medical Inc., which is Biofourmis’ joint venture partner for the China region.

March 4, 2020

Biofourmis Partners with ImagineMIC to Pioneer Collaborative Remote Patient Monitoring Model

Biofourmis, a fast-growing global leader in digital therapeutics that powers personally predictive care, and ImagineMIC™ announced a partnership agreement today to drive improved outcomes and lower healthcare costs for patients with chronic conditions. ImagineMIC™ is a revolutionary medical device company that delivers chronic care management through remote monitoring services and HIPAA-compliant technology.

January 30, 2020

Biofourmis Names Pharma and Tech Veterans as COO and CTO

Biofourmis, a fast-growing global leader in digital therapeutics that powers personally predictive care, has named two highly experienced and skilled business leaders with deep, highly relevant backgrounds as the company’s chief operating officer (COO) and chief technology officer (CTO).

January 27, 2020

Digital therapeutics leader Biofourmis to take part in pioneering heart failure research with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI)

Biofourmis, a fast-growing global leader in digital therapeutics, has entered a research partnership with the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI). Biofourmis’ mobile platform BiovitalsHFTM will be leveraged in a study of patients with heart failure to monitor functional capacity and quality of life to see if greater emphasis should be placed on these measures in the drug approval process.

July 16, 2019